YAP1 and brain neoplasm: Injection of the YAP1-FAM118B fusion by itself caused the formation of mouse brain tumors with a similar latency to RELAFUS1 tumors, which is unlike the reported better clinical outcomes compared to RELAFUS tumors in human patients (Fig. 5a, b) [20].